{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/angio-oedema-anaphylaxis/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"fab5c932-e15e-5303-99e9-48f7d2e415b4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field 3429c25d-aef2-496c-88de-f2019eb6007d --><h2>What else could it be?</h2><!-- end field 3429c25d-aef2-496c-88de-f2019eb6007d -->","summary":"","htmlStringContent":"<!-- begin item a93e7d13-170d-45e0-b44b-a96ce79f19ad --><!-- begin field 115e4e29-da17-4cb8-9647-fbff73cb5c90 --><ul><li><strong>Differential diagnoses of angio-oedema include:</strong><ul><li>Acute contact dermatitis — a person may have a history of contact with a sensitizing agent, with associated intense itching. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a>.</li><li>Cellulitis — acute onset of red, painful, hot, swollen, and tender skin often associated with fever. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cellulitis-acute/\">Cellulitis - acute</a>.</li><li>Connective tissue disorders — systemic lupus erythematosus is characterized by a butterfly rash on the face and features of systemic involvement.</li><li>Erysipelas — caused by Group A beta <em>Streptococcus</em> and presents with a facial rash which is well-defined and not fleeting, with associated tenderness and fever.</li><li>Idiopathic scrotal oedema in children — unknown aetiology but the swelling is limited to the scrotum.</li><li>Lymphoedema — chronic thickening of tissue, unlike the acute stretching seen in angio-oedema.</li><li>Rosenthal–Melkersson syndrome — causes recurrent non-resolving facial oedema, peripheral facial nerve palsy, and fissuring of the tongue.</li><li>Surgical abdomen — sometimes presents similarly to <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/background-information/causes-trigger-factors/\">hereditary or acquired angio-oedema</a>.</li></ul></li><li><strong>Differential diagnoses of anaphylaxis include:</strong><ul><li>Angio-oedema. </li><li>Asthma — a chronic respiratory condition associated with airway inflammation and hyper-responsiveness. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/asthma/\">Asthma</a>.</li><li>Acute anxiety (globus hystericus or panic attack). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>.</li><li>Breath-holding episode in a child.</li><li>Foreign body aspiration.</li><li>Hypoglycaemia (low blood glucose) — the main adverse effect of insulin treatment, generally defined as being present when blood glucose levels decrease to less than 3.5 mmol/L. For more information, see the sections on hypoglycaemia in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/insulin-therapy-in-type-1-diabetes/\">Insulin therapy in type 1 diabetes</a> or <a class=\"topic-reference external-reference\" href=\"/topics/insulin-therapy-in-type-2-diabetes/\">Insulin therapy in type 2 diabetes</a>.</li><li>Pulmonary embolism — a condition in which one or more emboli, usually arising from a blood clot formed in the veins (or, rarely, in the right heart) are lodged in and obstruct the pulmonary arterial system. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pulmonary-embolism/\">Pulmonary embolism</a>.</li><li>Urticaria. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urticaria/\">Urticaria</a>.</li><li>Vasovagal episode — transient loss of consciousness that resolves quickly. There is usually no evidence of airway symptoms.</li><li>Other conditions, including:<ul><li>Mastocytosis — a rare condition caused by an excess number of mast cells gathering in the body's tissues.</li><li>Carcinoid syndrome — a collection of symptoms experienced by some people when a carcinoid tumour (usually one that has spread to the liver) releases hormones (such as serotonin) into the bloodstream.</li><li>Scombroid poisoning (from contaminated fish).</li><li>Seizure disorder.</li><li>Septic shock.</li></ul></li></ul></li></ul><!-- end field 115e4e29-da17-4cb8-9647-fbff73cb5c90 --><!-- end item a93e7d13-170d-45e0-b44b-a96ce79f19ad -->","topic":{"id":"4e83ca20-0eac-5432-adf1-cb9a0716c558","topicId":"41b219ac-b62a-42d3-9d76-7b3897b21bdd","topicName":"Angio-oedema and anaphylaxis","slug":"angio-oedema-anaphylaxis","lastRevised":"Last revised in November 2018","chapters":[{"id":"f7de7576-f193-57e1-8566-52f77c198d07","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"137d41e2-195c-5b6c-a42b-a2e7774ab4c5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2d19b26a-ca5e-5feb-8be8-12f596f24eed","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"76defb8d-d620-56bc-bf42-cc72dd02704f","slug":"changes","fullItemName":"Changes"},{"id":"0124664c-1848-504a-b629-b001f3d627e7","slug":"update","fullItemName":"Update"}]},{"id":"fd3fe5d3-198d-5e2e-afaa-1de509ee14b0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8c36d3c5-8fc2-58ba-91d9-2d00dbb17605","slug":"goals","fullItemName":"Goals"},{"id":"dbfbfeb0-8ad4-5a3d-8458-06af672eab12","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bbc732dc-6fbc-5902-a5bf-890776f1df44","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"49ccfcd1-6054-5eac-b6a2-c85eb605ecfd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4c97855a-e489-54e6-8f4b-28dbc050951e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"71eafab9-7c66-5e57-aa08-197ad09eb9e7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2c158e9f-bfe1-56ea-a1fe-97e4da83b82d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ed1b7bb1-0232-5ceb-991c-c936ac2a3086","slug":"definition","fullItemName":"Definition"},{"id":"ac67665b-2b88-5df8-9a70-cc35f96825ae","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"a4358430-db1f-55c2-9d68-6ce8076813ba","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7ebee135-258e-58ce-a91e-947b8a2f9563","slug":"complications","fullItemName":"Complications"},{"id":"7c2a6ca1-0f6a-5a40-bc06-dbbbf95c57c1","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4b20303c-5905-594a-a8c6-4f85e46cf3f9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"005b06b8-18c4-569f-b1b3-3c6d1218ddf7","slug":"diagnosis-of-angio-oedema","fullItemName":"Diagnosis of angio-oedema"},{"id":"682e56cf-4c4d-5736-8db7-4cd4bfcab6e2","slug":"assessing-the-cause-of-angio-oedema","fullItemName":"Assessing the cause of angio-oedema"},{"id":"bf860a63-b9a4-5c14-bf1b-46423d3df7ad","slug":"diagnosis-of-anaphylaxis","fullItemName":"Diagnosis of anaphylaxis"},{"id":"fab5c932-e15e-5303-99e9-48f7d2e415b4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1c5f38ef-17d4-569d-ad54-b819fd953d6c","fullItemName":"Management","slug":"management","subChapters":[{"id":"654a5e70-49b7-58b4-b976-7e94c44b3074","slug":"angio-oedema-without-anaphylaxis","fullItemName":"Scenario: Angio-oedema without anaphylaxis"},{"id":"5759117d-4bde-53b6-b78d-7885ccbf431e","slug":"anaphylaxis-with-or-without-angio-oedema","fullItemName":"Scenario: Anaphylaxis with or without angio-oedema"}]},{"id":"6f94e28f-193d-587a-a11a-0a05a1be037f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b59ab8fd-de1f-555e-946a-c3a53b918da4","slug":"emergency-drug-doses","fullItemName":"Emergency drug doses"},{"id":"69e007b8-2046-5946-a7b5-de8f1bb9de9f","slug":"non-sedating-antihistamines-no-airway-involvement","fullItemName":"Non-sedating antihistamines (no airway involvement)"},{"id":"dac089ca-3b63-536d-9737-82806f78b88e","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"7ead2f48-36a4-5547-8570-4d4ab5898a73","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a7653e34-460d-5737-b0c3-264ecc26dc68","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a713ee82-3188-50ea-a2bc-a562abd97621","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7421fd02-2e34-5526-bd39-905aa772f800","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d24df800-eddc-5bf3-bea0-d556b5e01aed","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"af27ed5c-0853-5d16-91a4-5e5878ee9209","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f7640a76-8bc4-569e-8b82-717e6bd5f041","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b4778aa1-f37d-574f-8514-47ac86bf2c2e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4b20303c-5905-594a-a8c6-4f85e46cf3f9","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"5bc2f73d-9624-5452-b446-41ebee476900","slug":"basis-for-recommendation-fd5","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field ccb8b6d5-c369-4dbf-ae6f-29f676731c88 --><h3>Basis for recommendation</h3><!-- end field ccb8b6d5-c369-4dbf-ae6f-29f676731c88 -->","summary":null,"htmlStringContent":"<!-- begin item fd5fa475-0219-406b-aa7b-22e020c7f446 --><!-- begin field 76d0c9fc-05a2-4016-886b-9e8917e48241 --><ul><li>Information on the differential diagnoses of angio–oedema is taken from the <em>BSACI guideline for the management of chronic urticaria and angioedema </em>published by the British Society for Allergy and Clinical Immunology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Powell, 2015</a>], a <em>Position Paper on Hereditary Angioedema (HAE)</em> published by the Australasian Society of Clinical Immunology and Allergy (ASCIA) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">ASCIA, 2017</a>], and review articles on angio-oedema [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">DermNet NZ, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Cicardi, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">BMJ, 2016</a>].</li><li>Information on the differential diagnoses of anaphylaxis is taken from the <em>Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers </em>published by the Working Group of the Resuscitation Council (UK) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Resuscitation Council (UK), 2012</a>], <em>Anaphylaxis: a practice parameter update 2015</em> developed by the Joint Task Force on Practice Parameters [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Lieberman, 2015</a>], and a review article on anaphylaxis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">BMJ, 2017</a>].</li></ul><!-- end field 76d0c9fc-05a2-4016-886b-9e8917e48241 --><!-- end item fd5fa475-0219-406b-aa7b-22e020c7f446 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}